相关实验视频

Updated: Jul 7, 2025

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

从油修改的LPC20K改善了斯科波拉胺诱导的认知障碍

Keontae Park¹, Chang Hyeon Kong¹, Woo Chang Kang¹

¹Department of Biomedical and Pharmaceutical Science, Kyung Hee University, Seoul 02447, the Republic of Korea.

Behavioural brain research

|December 25, 2023

概括

在阿尔茨海默病模型中,油衍生物LPC20K改善了记忆和认知功能. 这种食补充剂增强了关键的大脑信号通路和来自大脑的神经营养因子 (BDNF) 的水平.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
老年学是一门学科.

背景情况:

阿尔茨海默氏症 (AD) 是老年人中普遍存在的一种神经退行性疾病,其特点是显著的认知障碍.
阿尔茨海默病的一个关键病理特征是胆固醇神经递质系统的功能障碍.
目前,阿尔茨海默病缺乏修改疾病的药物.

研究的目的:

调查油的潜力,特别是溶脂脂胆-多可萨赫酸 (LPC-DHA,LPC20K),作为治疗认知障碍的治疗剂.
评估LPC20K对各种记忆领域的影响,包括短期,长期,空间和对象识别记忆.
阐明LPC20K可以改善认知功能的潜在分子机制.

主要方法:

用LPC20K给表现出胆固醇低功能的动物模型.
使用一系列行为测试来评估认知功能.
关键信号分子的分析,包括蛋白质激酶C zeta (PKCζ),后突触密度蛋白95 (PSD-95),细胞外信号调节激酶 (ERK),Ca2+/卡尔莫杜林依赖蛋白激酶II (CaMKII),cAMP反应元素结合蛋白 (CREB) 和脑衍生神经营养因子 (BDNF) 通过西式涂抹.

主要成果:

在胆固醇低功能的条件下,LPC20K显著改善了短期,长期,空间和物体识别记忆缺陷.
使用LPC20K导致PKCζ和PSD-95.5的表达水平显著增加.
在LPC20K治疗组中,ERK,CaMKII和CREB的酸化水平显著升高,同时BDNF表达的时间增加.

结论:

LPC20K在改善与低胆固醇状态相关的认知障碍方面表现出有效性,这可能与阿尔茨海默病有关.
LPC20K的认知益处与关键信号通路 (PKCζ,PSD-95,ERK,CaMKII,CREB) 的上调以及BDNF水平的增加有关.
作为减轻像阿尔茨海默氏症这样以胆固醇功能障碍为特征的疾病的认知衰退的食补充剂,LPC20K具有前景.

关键词:

克里尔油的使用方法长期记忆长期记忆长期记忆 Lysophosphatidylcholine-docosahexaenoic 酸的作用是什么在MAPK/CaMKII-BDNF信号通路中.识别记忆识别记忆识别记忆

更多相关视频

Using Pharmacological Manipulation and High-precision Radio Telemetry to Study the Spatial Cognition in Free-ranging Animals

Using Pharmacological Manipulation and High-precision Radio Telemetry to Study the Spatial Cognition in Free-ranging Animals

Published on: November 6, 2016

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.